Hakan Düğer

8PUBLICATIONS
28CO-AUTHORS
EndocrinologyMolecular targetsToxicology (incl. clinical toxicology)Oncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 25, 2026
Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience.

|May 30, 2024
Impact of 24-week dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus.

Pınar Akhanli, Sema Hepşen, İsmail Emre Arslan

|Nov 03, 2023
Hypomagnesemia may be associated with symptomatic disease in patients with primary hyperparathyroidism.

Hakan Düğer, Bekir Uçan, Mustafa Çalışkan

|Jul 26, 2023
Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism.

Muhammed Kızılgül, Ömer Bayır, Bekir Uçan

|Mar 17, 2023
The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism.

H Düğer, H Bostan, Ü Gül

|May 25, 2022
Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature.

Muhammed Kizilgul, Hakan Duger, Narin Imga Nasiroglu

Pageof 2

Frequent Collaborators

6 joint publications

Muhammed Kızılgül

6 joint publications

Erman Cakal

5 joint publications

Bekir Uçan

4 joint publications

Muhammed Erkam Sencar